Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis#

• Erica Ramstad,
• Ole Jakob Storebø,
• Trine Gerner,
• Helle B. Krogh,
• Mathilde Holmskov,
• Frederik L. Magnusson,
• Carlos R. Moreira-Maia,
• Maria Skoog,
• Camilla Groth,
• Donna Gillies,
• Morris Zwi,
• Richard Kirubakaran,
• Christian Gluud,
• Erik Simonsen

Affiliations

Erica Ramstad

Child and Adolescent Psychiatric Department,Region Zealand,Denmark

Ole Jakob Storebø

Department of Psychology, Faculty of Health Science, University of Southern Denmark,Odense,Denmark

Trine Gerner

Psychiatric Research Unit,Region Zealand, Slagelse,Denmark

Helle B. Krogh

Child and Adolescent Psychiatric Department,Region Zealand,Denmark

Mathilde Holmskov

Psychiatric Research Unit,Region Zealand, Slagelse,Denmark

Frederik L. Magnusson

Psychiatric Research Unit,Region Zealand, Slagelse,Denmark

Carlos R. Moreira-Maia

Federal University of Rio Grande do Sul,Porto Alegre,Brazil

Maria Skoog

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital,Copenhagen,Denmark

Camilla Groth

Pediatric Department E, Herlev University Hospital,Herlev,Denmark

Donna Gillies

Western Sydney Local Health District; Mental Health,Parramatta,Australia

Morris Zwi

Islington CAMHS, Whittington Health,UK

Richard Kirubakaran

Cochrane South Asia, Prof. BV Moses Center for Evidence-Informed Health Care and Health Policy, Christian Medical College,Vellore,India

Christian Gluud

The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital,Copenhagen,Denmark

Erik Simonsen

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen,Denmark